Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2020 | PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. | CI |
2020 | PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. | CI |
Sales 2011 | 88.83M 7.41B | Sales 2012 | 94.55M 7.88B | Capitalization | 9.63M 803M |
---|---|---|---|---|---|
Net income 2011 | 13M 1.08B | Net income 2012 | 17M 1.42B | EV / Sales 2011 | 0.24 x |
Net cash position 2011 | 14.72M 1.23B | Net cash position 2012 | 26.92M 2.24B | EV / Sales 2012 | -0.18 x |
P/E ratio 2011 |
2.66
x | P/E ratio 2012 |
0.55
x | Employees | 171 |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 98.86% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Ferri
CEO | Chief Executive Officer | - | 19/18/19 |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.54K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- KALY Stock